Tag | Content |
---|
EnhancerAtlas ID | HS134-02782 |
Organism | Homo sapiens |
Tissue/cell | Mesendoderm |
Coordinate | chr1:110501940-110503960 |
Target genes | Number: 15 | Name | Ensembl ID |
|
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
HSF1 | MA0486.2 | chr1:110502314-110502327 | GAATATTCTGGAA | - | 6.46 | NR2F1 | MA0017.2 | chr1:110502767-110502780 | CTTTTGACCTTTG | - | 6.87 |
|
| Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
SE_32320 | chr1:110502294-110502773 | Gastric | SE_34099 | chr1:110500834-110504596 | HCC1954 | SE_47194 | chr1:110500087-110506717 | Panc1 | SE_50838 | chr1:110502272-110503454 | Sigmoid_Colon | SE_53269 | chr1:110502238-110503062 | Small_Intestine |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH01I109958 | chr1 | 110500903 | 110504624 |
|
Enhancer Sequence | CCAGCCTAGG CAACAGGAGA CTCTGTCAAA AAAAAAAAAA AAAATTAGAA TTTGGGTAGC 60 TTTGGAGGAG ATAGTTTGGG TGTGGAACGG AGTGAGGGGG ACCTCTAGTC ATTGTCATGG 120 TGATACTAAC CATCAAATAC TGAGCCTACA CTCCAAACAC ATCATTTCAT TAATCCTCAC 180 AATAAATCCT AACGTCAGTG GTATCACCCC AATTGTCAAA AGGAGGAAAC CAAACCTCAG 240 AAAACATTTT TGAGTTTCAA GGTCACAGAG CTAGTAAGTG GTTGAGCTGG GTTCAAACCC 300 AAACTCATTT GATTTCAAAG CATGTGCTCC AATTTTAACT TTTATTATCT TATTCTGAAT 360 AATCTGGGAG CTGAGAATAT TCTGGAAATA AAATCCAGGT TAGAGACCTG CCAAGAGCCT 420 AGACAGTGAG TTAAGCTGGG CTAAGGCACT GAGTAAACTC AGAAATGTCT GTTTGTCATC 480 TCCCTGTGCT TACTGCTCCT GTTGTTAAAG ATGTCTTAGC ATCTTAAACA ACTGAGCTTG 540 TGCTGAACCA GTGAACTACA TTGGGTGTGG GAGCTGGTCC TTGGGGGAAA AAAATCTCTC 600 CCTGCACCCA TATGTTTAGA AGCAGAAAGT TACCCGTGAT TTTAAGAAAG CTGCCTTTTA 660 GGAGACTGCC CTGGGCCTGG CTTATCACAT GAATACAGAA TACTGGTTTG CATTTCACCA 720 GCCTACATCA GATGTTTGTT TTAGCATACC ATACATTCTT AAAGCATGCG GGACAAGGAG 780 ATGCACTCCA GGAAGGGCCC TTTCAAAGTT TCGACTGGCT GTAACCTCTT TTGACCTTTG 840 CTCTAGTGCA CAGGCTCATC CTAGTCAAAG ACTTGTCTTC AGCATTACAA AATTTAGAAA 900 CCAACTCTGA ATTCACATGC ATTGTTTGCC AATGTTTTTC AAGTCTTCTC ACTTCCAGCT 960 GGATGGTCTT AAATGTACTC TGACCCACAC AGTTTCAGGC AAGTTGCAGA GCGCTTTGTA 1020 GGTATCCGAT AAGTATGCCC TGAATTGAGA GGCTAATTAA ACAAGAGGAA TTTAGCAATA 1080 TCACCTCTTG GCGTGAGTAT TATGTAGCAT CTGTAGTCGG GAGGGGTGGA GGGGTTGTAG 1140 AGCAGGGGTG ACTTCTTTAA AACCTCTCAG TTTGCATATA TGCCTCCCCT ACGAAAAGTC 1200 CTGCTGGTAA TAAACATAAT CTGCCCTGTG TGTTCCCACC ACAGGGGGGA CATATAGCAT 1260 GAATAAGAAC TGGCTTCCCT TAGAGAGCTT TTCCAAAGGA CACCATCTAT TTACTCAGCA 1320 AATATTTACT GAGCAAAATG GGAGGAGAAG GGCATTCTGG GGAGAGAGAA GAGTTTGAAC 1380 AAAGCTAAAA AGGAGGGAAA ACCAGGAGTA TGTATGGGAT ACACTGAATA GTCAAATTCA 1440 GGTGATAAAA TCTGAAAGGT AGGAGGGAAC TGATAAGTAG AGCTTTGAAT GCGTGGCAAG 1500 GAGTTTGGAC TTACTGAAAC AGGCAAAAGG GAGCCAAAGA AGATTTTGAG CAAGTGATAA 1560 ACATAATAAA AAATGCTTAT TAGGCAAGTT AATATGCCAG CAGTTCCTAA ATTGGACTGG 1620 GTTGAAGAAT AACAATATAA AGCAGCCAGC AATGATTGAG TAGTTACTAT GTACCCAGCA 1680 CCATGCCAAA CTCTTTGCAT ACATTTTCTC ATTTAATGAA AGTAATAATT AATGCATTTA 1740 AGACTCAGTG TCTGGCCCAT AATGTATTCC AACCCTCACA ATCATCCTGT AAATTGAGTA 1800 TTATTACCTC AGTTTTATAG GTGATGTCTA TATTGGTCTG TTTGCTATTG CTTATAACAG 1860 AATACCTGAA ACTGACTAAC TTCTAAAGAA GTTTATTTCT TACAGTGATG GAGGCTAAGA 1920 AGTCCCAGGC TGAGGGGCTG CATCTGGCGA GTCTTCTTGC TGGTAGGGAG TCCCCAGGTA 1980 GTTCGGGGCA CCCCATGGTG AGAGGCTGAG CAAGCTAATT 2020
|